Skip to main content
Signal8

HealthLynked Corp (HLYK) Form 10-Q — Nov 16, 2026

$HLYKForm 10-QFiled Nov 16, 2026, 3:55 PM ET0001213900-26-120571Original filing

HealthLynked Corp. filed its Q3 2026 10-Q reporting total revenue of $155,934 for the quarter, down roughly 60% from $388,545 a year earlier, with a nine-month net loss of $3,329,901. The company had just $16,594 in cash at September 30, 2026, against a working capital deficit of $1,416,099 and total liabilities of $10,101,376, and management stated that without additional funding it will not have sufficient funds to meet obligations within one year. Operations are heavily dependent on CEO Dr.

Key figures

Revenue
155934
Total Debt
10101376
Revenue Yoy
-59.9%
Cash Position
16594
Shares Outstanding
2970725
Dent Note Maturity
2029-02-02
Nine Month Revenue
829229
Q3 Prior Year Revenue
388545
Dent Note Interest Rate
12%
Dent Note Conversion Price
$2.75 (reduced from $4.25 in July 2026 down round)
Nine Month Prior Year Revenue
1755113
February2026 Dent Note Principal
5715812

AI analysis

Red flags7 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    HealthLynked Corp (HLYK) Form 10-Q — Nov 16, 2026: AI Analysis | Signal8